Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
AOM prescribing also increased each month between June and September 2025, with an overall increase of +6.7%
Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW
Survodutide side effects (Phase 2 data) Nausea: 56% of participants Vomiting: 27% Diarrhea: 22% Constipation: 21% Discontinuation due to adverse events: 24.6% Serious adverse events: 4.2% In the MASH trial, rates were even higher: nausea 66%, diarrhea 49%, vomiting 41%
Document your rationale (e.g., patient has obesity + BED, traditional BED treatments ineffective, GLP-1 may reduce binge frequency and aid weight loss) and get informed consent
US$ 20.03
US$ 24.99
US$ 26.33
US$ 24.58
US$ 25.55
